Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK cancer provision lags behind European neighbours:

This article was originally published in Clinica

Executive Summary

The UK has some of the lowest survival rates for common cancers, according to a European study. The Eurocare II report found that the UK lagged behind France, Germany, Italy and Spain when comparing five-year survival rates from 1978 to 1989 for lung, breast, colorectal and prostate cancer. UK survival rates were consistently below the European average and more in line with countries such as Poland and Estonia. Karol Sikora, head of the World Health Organisation's cancer programme, has called on the UK government to develop a national cancer centre to help achieve higher standards in care.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT077763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel